Skip to main content
Top

16-06-2018 | Cardiovascular disorders | Review | Article

Inpatient Glycemic Management of Non-cardiac CVD: Focus on Stroke and PVD

Journal: Current Diabetes Reports

Authors: Estelle Everett, Nestoras Mathioudakis

Publisher: Springer US

Abstract

Purpose of Review

Hyperglycemia occurs frequently in hospitalized patients with stroke and peripheral vascular disease (PVD). Guidelines for inpatient glycemic management are not well established for this patient population. We will review the clinical impact of hyperglycemia in this acute setting and review the evidence for glycemic control.

Recent Findings

Hyperglycemia in acute stroke is associated with poor short and long-term outcomes, and perioperative hyperglycemia in those undergoing revascularization for PVD is linked to increased post-surgical complications. Studies evaluating tight glucose control do not demonstrate improvement in clinical outcomes, although the risk for hypoglycemia increases substantially. Additional studies are needed to evaluate tight glucose goals relative to our current standard of care and the role of permissive hyperglycemia.

Summary

Given the limited data to guide glycemic management in these patient populations, it is recommended that general guidelines for inpatient glycemic control be followed. Special considerations should be made to address factors that may impact glucose management, including neurological deficits and clinical changes that occur in the postoperative state.
Literature
1.
Galindo RJ, Fayfman M. Perioperative management of hyperglycemia and diabetes in cardiac surgery patients. Endocrinol Metab Clin North Am. 2018;47:203–22. https://​doi.​org/​10.​1016/​J.​ECL.​2017.​10.​005.CrossRefPubMed
2.
Heyboer M, Sharma D, Santiago W, McCulloch N, McCulloch N. Hyperbaric oxygen therapy: side effects defined and quantified. Adv Wound Care. 2017;6:210–24. https://​doi.​org/​10.​1089/​wound.​2016.​0718.CrossRef
3.
Baker L, Juneja R, Bruno A. Management of hyperglycemia in acute ischemic stroke. Curr Treat Options Neurol. 2011;13:616–28. https://​doi.​org/​10.​1007/​s11940-011-0143-8.CrossRefPubMed
4.
Shimoyama T, Kimura K, Uemura J, Saji N, Shibazaki K. Elevated glucose level adversely affects infarct volume growth and neurological deterioration in non-diabetic stroke patients, but not diabetic stroke patients. Eur J Neurol. 2014;21:402–10. https://​doi.​org/​10.​1111/​ene.​12280.CrossRefPubMed
5.
Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med. 1983;74:540–4. https://​doi.​org/​10.​1016/​0002-9343(83)91007-0.CrossRefPubMed
6.
Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20–8. https://​doi.​org/​10.​1002/​ana.​10241.CrossRefPubMed
7.
Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurol Am Acad Neurol. 2002;59:669–74. https://​doi.​org/​10.​1212/​WNL.​59.​5.​669.CrossRef
8.
Ahmed N, Dávalos A, Eriksson N, Ford GA, Glahn J, Hennerici M, et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). Arch Neurol. 2010;67:1123–30. https://​doi.​org/​10.​1001/​archneurol.​2010.​210.CrossRefPubMed
9.
Jørgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke American Heart Association. Inc. 1994;25:1977–84. https://​doi.​org/​10.​1161/​01.​STR.​25.​10.​1977.CrossRef
10.
Golden SH, Hill-Briggs F, Williams K, Stolka K, Mayer RS. Management of diabetes during acute stroke and inpatient stroke rehabilitation. Arch Phys Med Rehabil. 2005;86:2377–84. https://​doi.​org/​10.​1016/​J.​APMR.​2005.​07.​306.CrossRefPubMed
11.
Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurol Am Acad Neurol. 2002;59:67–71. https://​doi.​org/​10.​1212/​WNL.​59.​1.​67.CrossRef
12.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–32.CrossRefPubMed
13.
Goyal N, Kaur R, Sud A, Ghorpade N, Gupta M. Non diabetic and stress induced hyperglycemia [SIH] in orthopaedic practice what do we know so far? J Clin Diagn Res. 2014;8:LH01–3. https://​doi.​org/​10.​7860/​JCDR/​2014/​10027.​5022.PubMedPubMedCentralCrossRef
14.
Kerby JD, Griffin RL, MacLennan P, Rue LW. Stress-induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Ann Surg. 2012;256:446–52. https://​doi.​org/​10.​1097/​SLA.​0b013e3182654549​.CrossRefPubMed
15.
Rau C-S, Wu S-C, Chen Y-C, Chien P-C, Hsieh H-Y, Kuo P-J, et al. Higher mortality in trauma patients is associated with stress-induced hyperglycemia, but not diabetic hyperglycemia: a cross-sectional analysis based on a propensity-score matching approach. Int J Environ Res Public Health. 2017;14:1161. https://​doi.​org/​10.​3390/​ijerph14101161.CrossRefPubMedCentral
16.
Sleiman I, Morandi A, Sabatini T, Ranhoff A, Ricci A, Rozzini R, et al. Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit. J Am Geriatr Soc. 2008;56:1106–10. https://​doi.​org/​10.​1111/​j.​1532-5415.​2008.​01729.​x.CrossRefPubMed
17.
Lazaros G, Tsiachris D, Vlachopoulos C, Chrysohoou C, Milkas A, Papageorgiou N, et al. Distinct association of admission hyperglycemia with one-year adverse outcome in diabetic and non-diabetic patients with acute ST-elevation myocardial infarction. Hell J Cardiol. 54:119–25.
18.
Hjalmarsson C, Manhem K, Bokemark L, Andersson B. The role of prestroke glycemic control on severity and outcome of acute ischemic stroke. Stroke Res Treat. 2014;2014:694569–6. https://​doi.​org/​10.​1155/​2014/​694569.PubMedPubMedCentralCrossRef
19.
Olsen TS. Blood glucose in acute stroke. Expert Rev Neurother. 2009;9:409–19. https://​doi.​org/​10.​1586/​14737175.​9.​3.​409.CrossRefPubMed
20.
Laird E. Blood glucose monitoring and management in acute stroke care. Nurs Stand. 2014;28:52–6. https://​doi.​org/​10.​7748/​ns2014.​01.​28.​19.​52.​e8163.CrossRefPubMed
21.
Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol. 2001;58:1209–12. https://​doi.​org/​10.​1001/​archneur.​58.​8.​1209.CrossRefPubMed
22.
Alvarez-Sabín J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator–treated patients. Stroke. 2003;34:1235–41. https://​doi.​org/​10.​1161/​01.​STR.​0000068406.​30514.​31.CrossRefPubMed
23.
Quinn TJ, Lees KR. Hyperglycaemia in acute stroke—to treat or not to treat. Cerebrovasc Dis. 2009;27(Suppl 1):148–55. https://​doi.​org/​10.​1159/​000200453.CrossRefPubMed
24.
Yoon J-E, Sunwoo J-S, Kim JS, Roh H, Ahn M-Y, Woo H-Y, et al. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients. J Diabetes Complicat. 2017;31:390–4. https://​doi.​org/​10.​1016/​J.​JDIACOMP.​2016.​11.​014.CrossRefPubMed
25.
Allport L, Baird T, Butcher K, Macgregor L, Prosser J, Colman P, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care. 2006;29:1839–44. https://​doi.​org/​10.​2337/​dc06-0204.CrossRefPubMed
26.
Paolino AS, Garner KM. Effects of hyperglycemia on neurologic outcome in stroke patients. J Neurosci Nurs. 2005;37:130–5. https://​doi.​org/​10.​1161/​hs1001.​096194.CrossRefPubMed
27.
Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21:246–9. https://​doi.​org/​10.​2337/​DIACARE.​21.​2.​246.CrossRefPubMed
28.
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82. https://​doi.​org/​10.​1210/​jcem.​87.​3.​8341.CrossRefPubMed
29.
Levetan CS. Effect of hyperglycemia on stroke outcomes. Endocr Pract. 2004;10:34–9. https://​doi.​org/​10.​4158/​EP.​10.​S2.​34.CrossRefPubMed
30.
Klingbeil KD, Koch S, Dave KR. Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation. Int J Stroke. 2017;0:174749301774379. https://​doi.​org/​10.​1177/​1747493017743797​.CrossRef
31.
Jin C, Li G, Rexrode KM, Gurol ME, Yuan X, Hui Y, et al. Prospective study of fasting blood glucose and intracerebral hemorrhagic risk. Stroke. 2018;49:27–33. https://​doi.​org/​10.​1161/​STROKEAHA.​117.​019189.CrossRefPubMed
32.
Brutsaert E, Carey M, Zonszein J. The clinical impact of inpatient hypoglycemia. J Diabetes Complicat. 2014;28:565–72. https://​doi.​org/​10.​1016/​J.​JDIACOMP.​2014.​03.​002.CrossRefPubMed
33.
Silverman IE, Restrepo L, Mathews GC. Poststroke Seizures. Arch Neurol. 2002;59:195–201. https://​doi.​org/​10.​1001/​archneur.​59.​2.​195.CrossRefPubMed
34.
Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32:1153–7. https://​doi.​org/​10.​2337/​dc08-2127.CrossRefPubMedPubMedCentral
35.
Akirov A, Grossman A, Shochat T, Shimon I. Mortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related. J Clin Endocrinol Metab. 2017;102:416–24. https://​doi.​org/​10.​1210/​jc.​2016-2653.CrossRefPubMed
36.
Bellolio MF, Gilmore RM, Ganti L. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev. 2014; https://​doi.​org/​10.​1002/​14651858.​CD005346.​pub4.
37.
Bruno A, Durkalski VL, Hall CE, Juneja R, Barsan WG, Janis S, et al. The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke. Int J Stroke. 2014;9:246–51. https://​doi.​org/​10.​1111/​ijs.​12045.CrossRefPubMed
38.
Johnston K. Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial (SHINE) [Internet]. U.S Natl. Libr. Med. 2017. Doi: https://​clinicaltrials.​gov/​ct2/​show/​NCT01369069
39.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:eXXX–X. https://​doi.​org/​10.​1161/​STR.​0000000000000158​.
40.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009:1119–31. https://​doi.​org/​10.​2337/​dc09-9029.
41.
Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16–38. https://​doi.​org/​10.​1210/​jcem.​97.​1.​zeg16a.CrossRefPubMed
42.
McGrath RT, Hocking SL, Priglinger M, Day S, Herkes GK, Krause M, et al. Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study. BMJ Open. 2016;6:e008203. https://​doi.​org/​10.​1136/​bmjopen-2015-008203.CrossRefPubMedPubMedCentral
43.
Daly SC, Chemmanam T, Loh P-S, Gilligan A, Dear AE, Simpson RW, et al. Exenatide in Acute Ischemic Stroke. Int J Stroke. 2013;8:E44. https://​doi.​org/​10.​1111/​ijs.​12073.CrossRefPubMed
44.
Singh S, Hamdy S. Dysphagia in stroke patients. Postgrad Med J. 2006;82:383–91. https://​doi.​org/​10.​1136/​pgmj.​2005.​043281.CrossRefPubMedPubMedCentral
45.
Wolpert HA, Atakov-Castillo A, Smith SA, Steil GM. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care. 2013;36:810–6. https://​doi.​org/​10.​2337/​dc12-0092.CrossRefPubMedPubMedCentral
46.
Mathioudakis N, Everett E, Golden SH. Prevention and management of insulin-associated hyoglycemia in hospitalized patients. Endocr Pract. 2016;22:959–69. https://​doi.​org/​10.​4158/​EP151119.​OR.CrossRefPubMedPubMedCentral
47.
Huysman F, Mathieu C. Diabetes and peripheral vascular disease. Acta Chir Belg. 2009;109:587–94. https://​doi.​org/​10.​1080/​00015458.​2009.​11680493.CrossRefPubMed
48.
Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33:13–8.CrossRefPubMed
49.
Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes—a review. Diabet Med. 2010;27:4–14. https://​doi.​org/​10.​1111/​j.​1464-5491.​2009.​02866.​x.CrossRefPubMed
50.
McGirt MJ, Woodworth GF, Brooke BS, Coon AL, Jain S, Buck D, et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery. 2006;58:1066–73. https://​doi.​org/​10.​1227/​01.​NEU.​0000215887.​59922.​36.CrossRefPubMed
51.
Davies MG, Saad WE. Impact of elevated perioperative fasting blood glucose on carotid artery stenting outcomes. Ann Vasc Surg. 2014;28:1885–91. https://​doi.​org/​10.​1016/​J.​AVSG.​2014.​07.​001.CrossRefPubMed
52.
Malmstedt J, Wahlberg E, Jörneskog G, Swedenborg J. Influence of perioperative blood glucose levels on outcome after infrainguinal bypass surgery in patients with diabetes. Br J Surg. 2006;93:1360–7. https://​doi.​org/​10.​1002/​bjs.​5466.CrossRefPubMed
53.
Steely AM, Smith L, Callas PW, Nathan MH, Lahiri JE, Stanley AC, et al. Prospective study of postoperative glycemic control with a standardized insulin infusion protocol after infrainguinal bypass and open abdominal aortic aneurysm repair. Ann Vasc Surg. 2017;44:211–20. https://​doi.​org/​10.​1016/​j.​avsg.​2017.​04.​020.CrossRefPubMed
54.
• Vogel TR, Smith JB, Kruse RL. The association of postoperative glycemic control and lower extremity procedure outcomes. J Vasc Surg. 2017;66:1123–32. https://​doi.​org/​10.​1016/​J.​JVS.​2017.​01.​053. This study highlights the range of complications that has been associated with post-operative hyperglycemia and odds of these complications after lower extremity vascular surgery.CrossRefPubMedPubMedCentral
55.
Nayak RK, Kirketerp-Møller K. Preoperative blood glucose and prognosis in diabetic patients undergoing lower extremity amputation. Dan Med J. 2016;63
56.
Arya S, Binney ZO, Khakharia A, Long CA, Brewster LP, Wilson PW, et al. High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg. 2018;67:217–228.e1. https://​doi.​org/​10.​1016/​j.​jvs.​2017.​06.​101.CrossRefPubMed
57.
Subramaniam B, Panzica PJ, Novack V, Mahmood F, Matyal R, Mitchell JD, et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery. Anesthesiology. 2009;110:970–7. https://​doi.​org/​10.​1097/​ALN.​0b013e3181a1005b​.CrossRefPubMed
58.
Feringa HHH, Vidakovic R, Karagiannis SE, Dunkelgrun M, Elhendy A, Boersma E, et al. Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med. 2008;25:314–9. https://​doi.​org/​10.​1111/​j.​1464-5491.​2007.​02352.​x.CrossRefPubMed
59.
Vriesendorp TM, Morélis QJ, DeVries JH, Legemate DA, Hoekstra JBL. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg. 2004;28:520–5. https://​doi.​org/​10.​1016/​J.​EJVS.​2004.​08.​006.CrossRefPubMed
60.
Ramos M, Khalpey Z, Lipsitz S, Steinberg J, Panizales MT, Zinner M, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Trans Meet Am Surg Assoc. 2008;126:228–34. https://​doi.​org/​10.​1097/​SLA.​0b013e31818990d1​.CrossRef
61.
Buchleitner AM, Martínez-Alonso M, Hernández M, Solà I, Mauricio D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev. 2012; https://​doi.​org/​10.​1002/​14651858.​CD007315.​pub2.
62.
Sathya B, Davis R, Taveira T, Whitlatch H, Wu W-C. Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2013;102:8–15. https://​doi.​org/​10.​1016/​J.​DIABRES.​2013.​05.​003.CrossRefPubMed
63.
American Diabetes Association AD. 14. Diabetes Care in the Hospital:Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41:S144–51. https://​doi.​org/​10.​2337/​dc18-S014.CrossRef
64.
•• Duggan EW, Carlson K, Umpierrez GE. Perioperative Hyperglycemia Management. Anesthesiology. 2017;126:547–60. https://​doi.​org/​10.​1097/​ALN.​0000000000001515​. This comprehensive review paper thoroughly describes the impact of surgical stress on glycemic control and articulates in detail how to manage hyperglycemia preoperatively and post-operatively.CrossRefPubMedPubMedCentral
65.
Hirsch J, Rushakoff R, Robinowitz D, Rouine-Rap K, Windham H. UCSF Diabetes Pre-Op Managment [Internet]. 2017. Doi: http://​ucsfprod.​logicnets.​com/​UCSF/​packages/​DiabetesPreOp_​20170417/​logicnets.​lns?​_​session=​54B6BE07F2F011
66.
Jokinen-Gordon H, Barry RC, Watson B, Covington DS. A retrospective analysis of adverse events in hyperbaric oxygen therapy (2012-2015). Adv Skin Wound Care. 2017;30:125–9. https://​doi.​org/​10.​1097/​01.​ASW.​0000508712.​86959.​c9.CrossRefPubMed
67.
Nwafor TS, Collins N. Managing low blood glucose levels in patients undergoing hyperbaric oxygen therapy. Ostomy Wound Manage. 2014;60:12–5.PubMed
68.
Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018;1411:153–65. https://​doi.​org/​10.​1111/​nyas.​13569.CrossRefPubMed

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »